Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human Cholecystokinin Antibodies:
anti-Mouse (Murine) Cholecystokinin Antibodies:
anti-Rat (Rattus) Cholecystokinin Antibodies:
Go to our pre-filtered search.
Cow (Bovine) Polyclonal Cholecystokinin Primary Antibody for WB - ABIN2778154
Roskos, Wallace, Weiss: Readability of consumer medication information for intranasal corticosteroid inhalers. in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2007
Show all 3 Pubmed References
Rat (Rattus) Polyclonal Cholecystokinin Primary Antibody for ICC, IHC - ABIN1858280
Dong, Wang, Zhang, Wang, Li, Kang, Tian, Fu: Cholecystokinin Expression in the Development of Postinfarction Heart Failure. in Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2017
This review explores the role of luminal cholecystokinin on the regulation of exocrine pancreatic secretion in author's studies of newborn calves.
We conclude that only a small fraction of neuronal CCK is nonsulfated. The intracellular distribution of nonsulfated CCK in neurons suggests that they contribute only modestly to the CCK transmitter activity.
Cardiac expression of pro-cholecystokinin is cell-specific, which differentiates the expression from that of intestinal endocrine cells and cerebral neurons.
This review explores the role of luminal cholecystokinin on the regulation of exocrine pancreatic secretion in author's studies of neonatal pigs.
L-trp (show TBPL1 Antibodies) is a luminal regulator of CCK release with effects on gastric emptying, an effect that could be mediated by CCK. L-trp's effect on GLP-1 (show GCG Antibodies) secretion is only minor. At the doses given, the two amino acids did not affect subjective appetite feelings.
The CCK polymorphism have reported significant association of -45C>T polymorphism with the presence of hallucinations.
CCK does not appear to play a unique independent role in satiety/satiation.
CCK release has been found to be halved in pregnant women with hyperemesis gravidarium, which supports the hypothesis that gastrointestinal motility is increased in pregnant women with hyperemesis gravidarium.
CCK in plasma is an independent marker of cardiovascular mortality in elderly female patients.
These data offer preliminary evidence supporting an association between the rs1799923 polymorphism in the CCK gene and PTSD
Data suggest that endocrine responses differ between jejunal and gastric enteral feeding, with higher peak plasma CCK (cholecystokinin), PYY (peptide YY), and GLP-1/2 (glucagon-like peptides 1/2) concentrations being attained after jejunal feeding.
active GLP-1 (show GCG Antibodies) produced in the islet stimulates cholecystokinin production and secretion in a paracrine manner via cyclic AMP (show APRT Antibodies) and CREB (show CREB1 Antibodies).
Cardiac expression of pro-cholecystokinin is cell-specific, which differentiates the expression from that of intestinal endocrine cells and cerebral neurons. Plasma Pro-CCK is a prognostic marker in patients with stable heart failure.
CCK binding modulates the contractile function of the lower esophageal sphincter through differential binding to the CCK-A receptor (show CCKAR Antibodies) on the sling and clasp (show CLASRP Antibodies) fibers
RIP2 (show ARHGDIG Antibodies)-knockout attenuates cardiac injury and dysfunction in hypertrophic heart. RIP2 (show ARHGDIG Antibodies)-deficience alleviates inflammation in heart of hypertrophic mice. RIP2 (show ARHGDIG Antibodies)-deletion inhibits fibrosis in the heart of hypertrophic mice.
CCK/GLP-1 (show GCG Antibodies) play contributory roles in anorexia induction by trichothecenes T-2 toxin, HT-2 toxin, diacetoxyscirpenol and neosolaniol.
GPR120 (show O3FAR1 Antibodies)-induced incretin glucse-dependent insulinotropic polypeptide secretion is indirectly mediated by cholecystokinin.
Medullary interstitial cells respond to body fluid expansion by CCK release for feedback regulation of the late proximal tubular reabsorption.
results suggest that normal integration of CCK+ basket cells in cortical networks is key to support spatial coding in the hippocampus.
this study reveals that LRRK2 is a new positive regulator of Rip2 (show ARHGDIG Antibodies) and promotes inflammatory cytokine induction through the Nod1 (show NOD1 Antibodies)/2-Rip2 (show ARHGDIG Antibodies) pathway.
PC7 (show PCSK7 Antibodies) has a critical role in normal processing of cholecystokinin in mouse brain
These studies reemphasize the beneficial effects imparted by co-administration of obestatin and CCK8 and their potential use towards countering obesity.
that Rip2 modifies VEGF-induced signalling and vascular permeability in myocardial ischaemia
new information on the cell specific localization of NUCB2/nesfatin-1 (show NUCB2 Antibodies) in the intestinal mucosa, and a novel function for nesfatin-1 (show NUCB2 Antibodies) in modulating intestinal CCK and PYY expression and secretion
Cholecystokinin is a brain/gut peptide. In the gut, it induces the release of pancreatic enzymes and the contraction of the gallbladder. In the brain, its physiologic role is unclear. The cholecystokinin pro-hormone is processed by endo- and exo-proteolytic cleavages. Two transcript variants encoding the same protein have been found for this gene.
, cholecystokinin triacontatriapeptide
, receptor-interacting serine/threonine-protein kinase 2
, tyrosine-protein kinase RIPK2
, Cholecystokinin type 2
, cholecystokinin (clone CCK-CH), preprocholecystokinin
, cholecystokinin B
, cholecystokinin type 2